(5Z)-7-bromo-4-chloro-N-ethyl-5-ethylidene-6-iminoquinazolin-2-amine;2-methylpropane
C16H22BrClN4 — CID 172596090
Data last refreshed: (MolForge compound catalog, from PubChem)
About (5Z)-7-bromo-4-chloro-N-ethyl-5-ethylidene-6-iminoquinazolin-2-amine;2-methylpropane
(5Z)-7-bromo-4-chloro-N-ethyl-5-ethylidene-6-iminoquinazolin-2-amine;2-methylpropane (PubChem CID 172596090) has the molecular formula C16H22BrClN4 and a molecular weight of 385.74 g/mol. Its IUPAC name is (5Z)-7-bromo-4-chloro-N-ethyl-5-ethylidene-6-iminoquinazolin-2-amine;2-methylpropane.
Molecular Properties
| Compound Name | (5Z)-7-bromo-4-chloro-N-ethyl-5-ethylidene-6-iminoquinazolin-2-amine;2-methylpropane |
|---|---|
| PubChem CID | 172596090 |
| Molecular Formula | C16H22BrClN4 |
| Molecular Weight | 385.74 g/mol |
| Exact Mass | 384.07 |
| IUPAC Name | (5Z)-7-bromo-4-chloro-N-ethyl-5-ethylidene-6-iminoquinazolin-2-amine;2-methylpropane |
| SMILES | CC(C)C.[H]/N=C1\C(Br)=Cc2nc(NCC)nc(Cl)c2\C1=C\C |
| InChI | InChI=1S/C12H12BrClN4.C4H10/c1-3-6-9-8(5-7(13)10(6)15)17-12(16-4-2)18-11(9)14;1-4(2)3/h3,5,15H,4H2,1-2H3,(H,16,17,18);4H,1-3H3/b6-3-,15-10-; |
| InChIKey | FQKKKWZXKCOXOF-IXEWYDTGSA-N |
| XLogP | 5.40 |
| TPSA | 61.66 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 22 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
|---|---|
| MW ≤ 500 | 385.74 |
| LogP ≤ 5 | 5.40 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 172596090 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.